177 related articles for article (PubMed ID: 22534149)
1. Mortality in hepatitis C virus-infected patients with a diagnosis of AIDS in the era of combination antiretroviral therapy.
Branch AD; Van Natta ML; Vachon ML; Dieterich DT; Meinert CL; Jabs DA;
Clin Infect Dis; 2012 Jul; 55(1):137-44. PubMed ID: 22534149
[TBL] [Abstract][Full Text] [Related]
2. Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?
Rockstroh JK; Peters L; Grint D; Soriano V; Reiss P; Monforte Ad; Beniowski M; Losso MH; Kirk O; Kupfer B; Mocroft A;
J Hepatol; 2013 Aug; 59(2):213-20. PubMed ID: 23583272
[TBL] [Abstract][Full Text] [Related]
3. Mortality in patients with chronic and cleared hepatitis C viral infection: a nationwide cohort study.
Omland LH; Krarup H; Jepsen P; Georgsen J; Harritshøj LH; Riisom K; Jacobsen SE; Schouenborg P; Christensen PB; Sørensen HT; Obel N;
J Hepatol; 2010 Jul; 53(1):36-42. PubMed ID: 20400197
[TBL] [Abstract][Full Text] [Related]
4. Comparison of deaths related to Hepatitis C and AIDS in Scotland.
Palmateer NE; Hutchinson SJ; McLeod A; Codere G; Goldberg DJ
J Viral Hepat; 2007 Dec; 14(12):870-4. PubMed ID: 18070290
[TBL] [Abstract][Full Text] [Related]
5. Effect of liver fibrosis on long-term mortality in HIV/hepatitis C virus-coinfected individuals who are evaluated to receive interferon therapies in the highly active antiretroviral therapy era.
Sanmartin R; de Felipe E; Tor J; Sanvicens A; Barluenga E; Martinez E; Muga R; Jou A; Ojanguren I; López JJ; Clotet B; Tural C
AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1235-43. PubMed ID: 22443303
[TBL] [Abstract][Full Text] [Related]
6. Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997.
van der Helm J; Geskus R; Sabin C; Meyer L; Del Amo J; Chêne G; Dorrucci M; Muga R; Porter K; Prins M;
Gastroenterology; 2013 Apr; 144(4):751-760.e2. PubMed ID: 23266560
[TBL] [Abstract][Full Text] [Related]
7. Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study.
Focà E; Fabbiani M; Prosperi M; Quiros Roldan E; Castelli F; Maggiolo F; Di Filippo E; Di Giambenedetto S; Gagliardini R; Saracino A; Di Pietro M; Gori A; Sighinolfi L; Pan A; Postorino MC; Torti C;
Medicine (Baltimore); 2016 Jul; 95(29):e4091. PubMed ID: 27442636
[TBL] [Abstract][Full Text] [Related]
8. Correlates of spontaneous clearance of hepatitis C virus in a Danish human immunodeficiency virus type 1 cohort.
Clausen LN; Weis N; Schønning K; Fenger M; Krarup H; Bukh J; Benfield T
Scand J Infect Dis; 2011 Oct; 43(10):798-803. PubMed ID: 21728744
[TBL] [Abstract][Full Text] [Related]
9. Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co-infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End-Stage Liver Disease as Compared to HCV Mono-infected Patients.
Salmon-Ceron D; Nahon P; Layese R; Bourcier V; Sogni P; Bani-Sadr F; Audureau E; Merchadou L; Dabis F; Wittkop L; Roudot-Thoraval F;
Hepatology; 2019 Sep; 70(3):939-954. PubMed ID: 30569448
[TBL] [Abstract][Full Text] [Related]
10. Differences in Response to Antiretroviral Therapy by Sex and Hepatitis C Infection Status.
Marcus JL; Leyden WA; Chao CR; Xu L; Quesenberry CP; Tien PC; Klein DB; Towner WJ; Horberg MA; Silverberg MJ
AIDS Patient Care STDS; 2015 Jul; 29(7):370-8. PubMed ID: 26061798
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus.
Mussini C; Lorenzini P; Puoti M; Lichtner M; Lapadula G; Di Giambenedetto S; Antinori A; Madeddu G; Cozzi-Lepri A; d'Arminio Monforte A; De Luca A;
PLoS One; 2015; 10(12):e0140877. PubMed ID: 26640953
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus (HCV) RNA profiles among chronic HIV/HCV-coinfected individuals in ESPRIT; spontaneous HCV RNA clearance observed in nine individuals.
Grint D; Tedaldi E; Peters L; Mocroft A; Edlin B; Gallien S; Klinker H; Boesecke C; Kokordelis P; Rockstroh JK
HIV Med; 2017 Jul; 18(6):430-434. PubMed ID: 27785892
[TBL] [Abstract][Full Text] [Related]
13. Chronic hepatitis C virus infection is associated with all-cause and liver-related mortality in a cohort of HIV-infected patients with alcohol problems.
Fuster D; Cheng DM; Quinn EK; Nunes D; Saitz R; Samet JH; Tsui JI
Addiction; 2014 Jan; 109(1):62-70. PubMed ID: 24112091
[TBL] [Abstract][Full Text] [Related]
14. Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus/hepatitis C virus coinfection.
Berenguer J; Rodríguez-Castellano E; Carrero A; Von Wichmann MA; Montero M; Galindo MJ; Mallolas J; Crespo M; Téllez MJ; Quereda C; Sanz J; Barros C; Tural C; Santos I; Pulido F; Guardiola JM; Rubio R; Ortega E; Montes ML; Jusdado JJ; Gaspar G; Esteban H; Bellón JM; González-García J;
Hepatology; 2017 Aug; 66(2):344-356. PubMed ID: 28109003
[TBL] [Abstract][Full Text] [Related]
15. Comparison of clinical outcomes between HIV-infected patients with and without HCV co-infection in a resource-limited setting.
Than NN; Sungkanuparph S; Maek-A-Nantawat W; Kaewkungwal J; Pitisuttithum P
Southeast Asian J Trop Med Public Health; 2012 May; 43(3):646-51. PubMed ID: 23077844
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous hepatitis C virus clearance in HIV patients with chronic hepatitis C bearing IL28B-CC alleles using antiretroviral therapy.
Vispo E; Barreiro P; Plaza Z; Fernández-Montero JV; Labarga P; de Mendoza C; Sierra-Enguita R; Treviño A; Lopez M; Soriano V
AIDS; 2014 Jun; 28(10):1473-8. PubMed ID: 24637541
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study.
; Peters L; Neuhaus J; Mocroft A; Soriano V; Rockstroh J; Dore G; Puoti M; Tedaldi E; Clotet B; Kupfer B; Lundgren JD; Klein MB
Antivir Ther; 2011; 16(5):667-75. PubMed ID: 21817188
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C and progression of HIV disease.
Sulkowski MS; Moore RD; Mehta SH; Chaisson RE; Thomas DL
JAMA; 2002 Jul; 288(2):199-206. PubMed ID: 12095384
[TBL] [Abstract][Full Text] [Related]
19. Stability of hepatitis C virus (HCV) RNA levels among interferon-naïve HIV/HCV-coinfected individuals treated with combination antiretroviral therapy.
Grint D; Peters L; Reekie J; Soriano V; Kirk O; Knysz B; Suetnov O; Lazzarin A; Ledergerber B; Rockstroh JK; Mocroft A;
HIV Med; 2013 Jul; 14(6):370-8. PubMed ID: 23534815
[TBL] [Abstract][Full Text] [Related]
20. Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV/AIDS treatment program.
Braitstein P; Zala C; Yip B; Brinkhof MW; Moore D; Hogg RS; Montaner JS
J Infect Dis; 2006 Jan; 193(2):259-68. PubMed ID: 16362890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
